Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.58 USD | -0.76% | -0.28% | -0.73% |
Jun. 08 | US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59 | RE |
Jun. 07 | Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds | RE |
Official Publications
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Official Publications